Skip to search formSkip to main contentSkip to account menu

12-Item Multiple Sclerosis Walking Scale Questionnaire

Known as: MSWS-12, MSWS01 
A standardized rating scale developed by Hobart et al in 2003, which is used to measure the impact of multiple sclerosis (MS) on an individual's… 
National Institutes of Health

Related topics

Related topics

2 relations
CDISC Questionnaire Category TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Fampridina na Esclerose Múltipla – para além da marcha
Objetivos: E objetivo do estudo a avaliacao do impacto da Fampridina na marcha, equilibrio, nivel funcional e percecao da… 
2017
2017
Avaliação Preliminar da Fampridina na Esclerose Múltipla: Para Além da Velocidade da Marcha
Introduction : The purpose of this study is to assess the impact of fampridine on walking, balance and perception of walking… 
2017
2017
Neuromuscular Determinants of Manual Dexterity and Walking Performance in Healthy Individuals and Persons with Multiple Sclerosis
2016
2016
Neurophysiological Profile, Walking Performance Tests and Self-Reported Questionnaires in Spastic Patients with MS: A Pilot Study
Nabiximols is currently being used as an add-on therapeutic option to treat severe forms of multiple sclerosis (MS) spasticity… 
2015
2015
Validity of mobility measures in multiple sclerosis, according disability level: a RIMS multi-center study.
Background: Psychometric properties of walking measures in pwMS (persons with MS) are well investigated, however there is limited… 
2015
2015
Tolerance and Efficacy of Fampyra® in Real-Life Cohort of Patients with Multiple Sclerosis
Background: Prolonged-release Fampridine is a selective potassium channel blocker licensed for the improvement of walking in… 
2015
2015
Identifying a Minimally Important Change Threshold for The Multiple Sclerosis Walking Scale-12 (MSWS-12)
Background: The 12-question Multiple Sclerosis (MS) Walking Scale (MSWS-12v1) is a widely-used patient-reported outcome (PRO… 
2012
2012
RESULTS FROM THE CANNABINNOID USE IN PROGRESSIVE INFLAMMATORY BRAIN DISEASE (CUPID) TRIAL
Cannabinoids have been shown to reduce MS-related symptoms, as well as potentially having a longer-term beneficial effect. This… 
2010
2010
Assessing neuronal metabolism in MS by modelling imaging measures.
Introduction The role of mitochondrial dysfunction in the pathogenesis of MS is becoming increasingly evident. H-MR spectroscopy… 
2004
2004
The multiple sclerosis walking scale (MSWS-12) and ambulatory activity analysis [Abstract]